EnVision Endoscopy Secures $11.5 Million Series A Funding and Completes First 50 Patient Procedures
EnVision Endoscopy has successfully closed an oversubscribed $11.5 million Series A financing round to accelerate the commercial expansion of its SimpleStitch™ Suturing System. The funding was led by Puma Venture Capital, with participation from UTEC – University of Tokyo Edge Capital, MassVentures, and existing investor Olympus Corporation of the Americas. In addition to the capital raise, the company announced it has reached a clinical milestone by completing its first 50 patient procedures using the SimpleStitch™ system. Following FDA clearance in 2025, this limited U.S. market release aims to transition the technology from development to widespread clinical adoption, making endoscopic suturing more accessible for gastrointestinal procedures.
Topics: Clinical Adoption Endoscopic Surgery Medical Device Launch Series A Financing